News — Lucid Capital Markets

LATEST NEWS

Press Releases & News Alerts

FEB 7, 2025

Lucid Acts as Sole Bookrunner for Nuvectis Pharma’s $15.5M Follow-on Offering

DEC 31, 2024

DEC 4, 2024

Lucid Acts as Lead Bookrunner for Eagle Point Credit Company $100 Million Notes Offering

NOV 21, 2024

JUN 26, 2024

Lucid Acts as Lead Left Bookrunner on $100M note offering of Oxford Lane Capital Corp

AUG 21, 2024

Lucid Established Healthcare Equity Research Group with Addition of Christopher Liu and Dev Prasad

JUL 23, 2024

Lucid Establishes Specialty Finance Equity Research Group with the Hiring of Erik Zwick

JUL 19, 2024

Lucid Establishes REIT Equity Research Group with the Hiring of Craig Kucera

JUL 09, 2024

Lucid is named lead placement agent on Saratoga Investment Corporation’s $300 million ATM program

JUN 18, 2024

Lucid acts as Lead Bookrunner on the $69 million IPO of Flagship Acquisition Corp.

JUN 07, 2024

Lucid is named sole bookrunner of Rising Dragon Acquisition Corp.’s $50 million IPO

MAY 10, 2024

Lucid Provides Fairness Opinion in Connection with Galera’s Acquisition of Nova Pharmaceuticals

Lucid is named sole bookrunner of YHN Acquisition Corp.’s $60 million IPO

APR 03, 2024

Lucid Acts as Lead Bookrunner for Ramaco Resources $50 Million Senior Notes Offering

Lucid is Named as Financial Advisor to ARCA Biopharma in a Reverse Merger Transaction with Oruka Therapeutics

APR 03, 2024

Lucid is Named as Financial Advisor to Kintara Therapeutics in a Reverse Merger Transaction with TuHura Biosciences

For press and news enquiries, please contact our team.

PRESS ENQUIRIES